(R)-(-)-2-Chloromandelic Acid - CAS 52950-18-2
Catalog: |
BB027997 |
Product Name: |
(R)-(-)-2-Chloromandelic Acid |
CAS: |
52950-18-2 |
Synonyms: |
(2R)-2-(2-chlorophenyl)-2-hydroxyacetic acid; (2R)-2-(2-chlorophenyl)-2-hydroxyacetic acid |
IUPAC Name: | (2R)-2-(2-chlorophenyl)-2-hydroxyacetic acid |
Description: | Clopidogrel intermediate. |
Molecular Weight: | 186.59 |
Molecular Formula: | C8H7ClO3 |
Canonical SMILES: | C1=CC=C(C(=C1)C(C(=O)O)O)Cl |
InChI: | InChI=1S/C8H7ClO3/c9-6-4-2-1-3-5(6)7(10)8(11)12/h1-4,7,10H,(H,11,12)/t7-/m1/s1 |
InChI Key: | RWOLDZZTBNYTMS-SSDOTTSWSA-N |
Boiling Point: | 350.3 °C at 760 mmHg |
Density: | 1.48 g/cm3 |
MDL: | MFCD00798429 |
LogP: | 1.45800 |
GHS Hazard Statement: | H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin] |
Precautionary Statement: | P261, P272, P280, P302+P352, P305+P351+P338, P310, P321, P333+P313, P363, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-111778199-A | Bacillus subtilis and application thereof | 20200907 |
CN-111778199-B | Bacillus subtilis and application thereof | 20200907 |
CN-111484986-A | Short-chain dehydrogenase and application thereof | 20200424 |
WO-2021202796-A1 | Pyrrolidine-pyrazoles as pyruvate kinase activators | 20200401 |
CN-111116655-A | Preparation method of high-optical-purity tenofovir benzyl ester phosphonamide prodrug | 20191230 |
PMID | Publication Date | Title | Journal |
22454104 | 20120701 | Efficient production of (R)-o-chloromandelic acid by deracemization of o-chloromandelonitrile with a new nitrilase mined from Labrenzia aggregata | Applied microbiology and biotechnology |
22508329 | 20120501 | Resolution of 2-chloromandelic acid with (R)-(+)-N-benzyl-1-phenylethylamine: chiral discrimination mechanism | Chirality |
22117223 | 20120214 | The isolation of a metastable conglomerate using a combined computational and controlled crystallization approach | Chemical communications (Cambridge, England) |
18837015 | 20090501 | Identification and characterization of solid-state nature of 2-chloromandelic acid | Journal of pharmaceutical sciences |
16936066 | 20070401 | The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans | Drug metabolism and disposition: the biological fate of chemicals |
Complexity: | 172 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 186.0083718 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 186.0083718 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 57.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
-
[89908-23-6]
2-Propenoic acid, 2-(3',3'-dimethyl-6-nitrospiro[2H-1-benzopyran-2,2'-[2H]indol]-1'(3'H)-yl)ethyl ester
-
[1427004-19-0]
DBCO-PEG4-NHS ester
-
[1383427-98-2]
(S)-Hexahydropyrazino[2,1-c][1,4]oxazin-4(3H)-one hydrochloride
-
[1006443-01-1]
1-(5-Nitropyridin-2-yl)-1H-pyrazole-3-carboxylic acid
-
[70912-52-6]
1,3-Dioxane-4,6-dione,2,2-dimethyl-5-(2-pyrrolidinylidene)-
-
[69616-74-6]
2',4-Dihydroxy-3',4',6'-trimethoxychalcone
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS